Log In
Print
BCIQ
Print
Print this Print this
 

sodium oxybate (Xyrem) (JZP-6)

Also known as: KEY-10

  Manage Alerts
Collapse Summary General Information
Company Jazz Pharmaceuticals plc
DescriptionOral liquid formulation of the sodium salt of gamma hydroxybutyrate (GHB)
Molecular Target GABA B receptor
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationExcessive sleepiness
Indication DetailsTreat cataplexy associated with narcolepsy; Treat excessive daytime sleepiness (EDS) associated with narcolepsy; Treat excessive daytime sleepiness (EDS) in combination with different stimulant medications; Treat excessive daytime sleepiness (EDS), fragmented nighttime sleep and cataplexy; Treat narcolepsy; Treat narcolepsy and reduce cataplexy; Treat narcolepsy with cataplexy in adult patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today